On Thursday, 1634 stocks advanced, 2582 declined, and 169 remained unchanged on the Bombay Stock Exchange with an advance-decline ratio of 0.63, indicating a negative closing. The trend of the major indices on Thursday’s trading is given in the table below.
On NSE, 27 securities advanced and closed at a new 52-week high, whereas 62 securities sank to close at their new 52-week lows. Nifty India Defence and Nifty Metal were the biggest gainer. Nifty IT, Nifty Media and Nifty Energy were the biggest losers.
Zydus Lifesciences (+2.52%) announced a major settlement agreement with Astellas Pharma, concluding the U.S. patent litigation surrounding Myrbetriq® (Mirabegron). The agreement also involves Zydus Pharmaceuticals USA, Inc., its wholly owned subsidiary. Zydus will pay Astellas an aggregate settlement amount of $120 million. In addition, Zydus will pay a prepaid per‑unit licensing fee on units of generic Mirabegron sold in the U.S. until September 2027. The settlement resolves all ongoing litigations between Astellas and Zydus related to Myrbetriq® and Mirabegron in the U.S. market. Importantly, the agreement enables Zydus to continue marketing its generic Mirabegron in the United States without legal uncertainty.
Ceigall India (+0.93%) secured a significant infrastructure contract worth ₹2,160 crore from the National Highways Authority of India (NHAI) for the four‑laning of NH‑139W in Bihar. Project involves construction of a 4‑lane highway stretch covering 78.942 km in Bihar under the Hybrid Annuity Mode (HAM). Construction period set at 730 days, followed by a 15‑year O&M phase for long‑term asset management.
Mastek Limited (-5.30%) expanded its Leeds office, marking a key milestone in its UK investment strategy and reinforcing its presence in the North of England. The expanded facility was inaugurated by Abhishek Singh, President – UKI & EU, Mastek, alongside Tracy Brabin, Mayor of West Yorkshire. The new Leeds office provides 100 seats, with capacity to scale further as business requirements grow. Expansion reflects Mastek’s growing focus on AI‑first digital engineering and cloud transformation services.
Hindustan Unilever (-2.16%) (HUL) announced that its Board has approved the acquisition of the remaining 49% stake in Zywie Ventures, which will make OZiva and its wholly owned subsidiary Zenherb Labs Private Limited. Zywie Ventures reported turnover of ₹257.67 crore in FY25, operating in the Health & Wellbeing segment (vitamins, minerals, supplements, beauty & personal care, protein products). Post‑transaction, HUL will hold 100% ownership of Zywie Ventures.
Black Box (-0.76%) announced the acquisition of 2S Inovações Tecnológicas (“2S”), a leading Brazilian IT infrastructure and managed services integrator, in a deal valued at around ₹275 crore. Black Box will acquire 100% equity stake in 2S. Acquisition strengthens Black Box’s footprint in Latin America, adding scale in IT infrastructure and managed services. The transaction is being executed through Black Box Do Brasil Indústria E Comércio Ltda., a step‑down subsidiary of the company.
Gujarat Fluorochemicals (-3.00%) reported Q3 FY26 performance Revenue from operations: ₹1,136 crore, down 1% y‑o‑y from ₹1,148 crore in Q3 FY25. Net profit was ₹103 crore, down 18.3% y o y from ₹126 crore in the corresponding quarter last year.
Welspun Living (+1.70%) reported Q3 FY26 performance with consolidated revenue falling 9.1% y‑o‑y to ₹2,262 crore, compared with ₹2,490 crore in the same quarter last year. Net profit plunged 99.8% to just ₹21 lakh.
Knowledge Marine & Engineering Works (-1.48%) reported Q3 FY26 performance with consolidated revenue rising 56.3% y o y to ₹90.0 crore, compared with ₹57.6 crore in the same quarter last year. Net profit surged 91.2% y o y to ₹30.4 crore, versus ₹15.9 crore in the corresponding period last year.
RedTape (+2.07%) reported Q3 FY26 performance with net profit rising 43.2% y‑o‑y to ₹104.5 crore, compared with ₹73 crore in the corresponding quarter last year. Revenue climbed 19% y‑o‑y to ₹786.5 crore, versus ₹661 crore in the year‑ago period.
Natco Pharma (-1.29%) reported strong Q3FY26 - Revenue from operations was ₹647.3 crore, up 36.3% y‑o‑y from ₹474.8 crore in Q3FY24-25. Net profit was ₹151.3 crore, up 14.3% y‑o‑y from ₹132.4 crore in the corresponding quarter last year.
West Coast Paper Mills (-4.64%) posted its Q3 FY26 results with revenue from operations rising 3.3% y‑o‑y to ₹1,049.8 crore, compared with ₹1,016 crore in the same quarter last year. Despite the modest topline growth, net profit declined sharply by 58% y‑o‑y to ₹27 crore, against ₹64.2 crore in the corresponding quarter of the previous fiscal.
Astra Microwave Products (+1.01%) reported Q3 FY26 results with net profit of ₹46.8 crore, down 1.3% y‑o‑y compared with ₹47.4 crore in the same period last year. Revenue rose 1% y‑o‑y to ₹260 crore.
The top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices are given in the table below:
